Cargando…
Risk stratification for early-onset fetal growth restriction in women with abnormal serum biomarkers: a retrospective cohort study
Abnormal maternal serum biomarkers (AMSB), identified through the aneuploidy screening programme, are frequent incidental findings in pregnancy. They are associated with fetal growth restriction (FGR), but previous studies have not examined whether this association is with early-onset (< 34 weeks...
Autores principales: | Ormesher, L., Warrander, L., Liu, Y., Thomas, S., Simcox, L., Smith, G. C. S., Myers, J. E., Johnstone, E. D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746767/ https://www.ncbi.nlm.nih.gov/pubmed/33335122 http://dx.doi.org/10.1038/s41598-020-78631-5 |
Ejemplares similares
-
Fractional fetal thigh volume in the prediction of normal and abnormal fetal growth during the third trimester of pregnancy
por: Simcox, Louise E., et al.
Publicado: (2017) -
Thrombophilia and Pregnancy Complications
por: Simcox, Louise E., et al.
Publicado: (2015) -
Pulmonary thrombo-embolism in pregnancy: diagnosis and management
por: Simcox, Louise E., et al.
Publicado: (2015) -
The effect of prone positioning on maternal haemodynamics and fetal wellbeing in the third trimester–A primary cohort study with a scoping review
por: Ormesher, Laura, et al.
Publicado: (2023) -
Outcome of early‐onset fetal growth restriction with or without abnormal umbilical artery Doppler flow
por: Gairabekova, Diana, et al.
Publicado: (2021)